Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
INTRODUCTION Blood sampling for combined first-trimester aneuploidy screening (cFTS) can be conducted from 8 weeks' gestation1-3, whereas the first-trimester scan must be performed at 11–14 weeks4. The best performance of cFTS, including measurement of pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (β-hCG), is obtained when blood is collected before 11 weeks3, 5-8.
What are the novel findings of this work? Placental growth factor (PlGF) in blood samples collected at 10 weeks' gestation had similar discriminatory value to PlGF collected at 11–14 weeks' gestation for prediction of preterm pre-eclampsia using the Fetal Medicine Foundation (FMF) screening algorithm. The discriminatory value of PlGF was relatively poor using samples collected earlier than 10 weeks' gestation. What are the clinical implications of this work?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.